BIAF Projected Dividend Yield
Bioaffinity Technologies Inc ( NASDAQ : BIAF )bioAffinity Technologies and its subsidiary, OncoSelect Therapeutics, LLC are engaged in developing noninvasive diagnostic tests and targeted cancer therapeutics. 20 YEAR PERFORMANCE RESULTS |
BIAF Dividend History Detail BIAF Dividend News BIAF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |